Syncell, a leading biotech company pioneering in platforms for hypothesis-free spatial proteomics, is excited to be exhibiting and presenting a poster at the upcoming AACR Annual Meeting 2023 in Orlando, FL.
With their ground-breaking Microscoop technology, researchers can now harness microscopy-guided subcellular protein scooping in ultra-detail, powered by AI for accurate subsequent spatial proteomic identification.
And now, Syncell is proud to announce that their first commercial Microscoop platform, Microscoop Mint, is available for order. To further support their customers, Syncell has also expanded their Global Rapid Access Service Program (GRASP) to include their new Microscoop technology.
Syncell’s Microscoop technology is revolutionizing life science research by offering a direct spatial proteomic discovery solution to identify novel protein biomarkers. We are thrilled to see the high demand of our services for a variety of life science research projects, and are proud to have achieved successful proteomic discoveries for our customers.
We believe Microscoop technology will be instrumental in advancing cancer research, and are excited to see what the future holds for this innovative technology.
Come visit Syncell at Booth #129 at the exhibit hall and discover our revolutionary new product and technology! On April 18th, from 1:30 pm – 5:00 pm, come to Section 23 for our poster presentation titled “Total-Sync Ultra-Content Microscopic Opto-Biotinylation Enables High-Sensitivity Hypothesis-Free Subcellular Protein Discovery”. Copies of the poster will be available at our booth, so make sure to check it out and see what our technology can do!
About Syncell
At Syncell, we are revolutionizing the field of spatial proteomics and protein biomarker discovery with our Microscoop technology. By enabling high-precision subcellular protein scooping and identification, our technology provides an unprecedented level of accuracy and detail in biomarker discovery.
We are committed to helping customers in academia, the pharmaceutical industry, and medical institutes by supplying cutting-edge instruments, reagents, and partnerships. Through our innovative platforms and methodology, Syncell is driving the boundaries of biomedical research and discovery.